Pregnancy SmartShop formulas

Is it safe? · Pregnancy Smart

When is sperm DNA fragmentation testing useful?

Assigned clinical reviewerMichael Yuzefovich· MD, FACOGDraft · pending clinical reviewUpdated

What does the evidence say about sperm DNA fragmentation testing?

  1. AUA/ASRM guidance does not recommend sperm DNA fragmentation testing in the initial evaluation of every infertile couple. Start with reproductive history, semen analysis and appropriate examination. An advanced test should answer a clinical question rather than simply add another number to a report. 1
  2. Sperm number, movement and shape do not directly measure every aspect of DNA integrity. A normal routine semen profile therefore does not make a fragmentation result redundant, but it also does not establish that everyone with a normal profile needs the additional test. 2
  3. Different assays examine DNA damage in different ways, and interpretation lacks a single globally accepted cutoff. The clinician survey documents variation in laboratory methods and practice. Ask which assay was used and avoid comparing percentages from unlike methods as if they were interchangeable. 3
  4. ASRM’s 2026 recurrent-loss guidance says testing may be considered with otherwise unexplained recurrent miscarriage or recurrent miscarriage alongside infertility. An abnormal result can prompt reproductive-urology evaluation. The same guidance notes that better-controlled evidence is needed to show that interventions improve pregnancy outcomes. 4
  5. A high fragmentation result does not establish a proven supplement regimen. AUA/ASRM describes uncertain clinical utility for male-fertility supplements. Review medicines, exposures and relevant medical findings with a specialist instead of assuming an antioxidant package guarantees a better reproductive outcome. 5

Before ordering an additional fertility test

  • Ask which specific clinical question the test is intended to answer.
  • Confirm the assay, collection instructions and laboratory interpretation.
  • Agree on the next step for either result before assuming more testing means better outcomes.

Frequently asked questions

Is this already included in a standard semen analysis?

Usually it is a separate assessment of DNA integrity. The usual count, motility and morphology measurements describe other sperm features.

Should every couple order it before trying fertility care?

No. AUA/ASRM does not recommend it as a routine initial test. Ask what specific history or finding makes it useful in your situation.

Can it be considered after recurrent miscarriage?

Yes, in selected cases such as otherwise unexplained recurrent miscarriage or recurrent loss with infertility. Discuss it within the broader evaluation rather than as a single explanation for every loss.

Is one percentage the cutoff for every laboratory?

No. Assay methods and reference values differ. Use the laboratory’s validated interpretation with a specialist, and identify the method when comparing reports.

Can fragmentation be high when count and motility look normal?

These tests measure different features, so that combination is possible. It does not by itself prove why a pregnancy has not occurred or what next step will help.

Does lowering the number guarantee fewer miscarriages?

No. Associations between fragmentation and loss do not establish that every intervention improves pregnancy outcomes. The current guideline identifies important evidence gaps.

Should I start a high-dose antioxidant combination?

Do not assume a supplement is the established answer. Evidence for specific male-fertility supplements remains uncertain, and the clinician should review possible causes and the overall plan.

What should I ask before paying for testing?

Ask which method the laboratory uses, what preparation is required, how a result would change care and whether repeat testing would be comparable. The test should serve a defined decision.

References

  1. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I

    American Society for Reproductive Medicine · https://www.asrm.org/practice-guidance/practice-committee-documents/diagnosis-and-treatment-of-infertility-in-men-auaasrm-guideline-part-i-2020/

  2. Recurrent pregnancy loss: a committee opinion

    American Society for Reproductive Medicine · https://www.asrm.org/practice-guidance/practice-committee-documents/recurrent-pregnancy-loss-a-committee-opinion-2026/

  3. Diagnosis and Treatment of Infertility in Men: AUA/ ASRM Guideline Part II

    American Society for Reproductive Medicine · https://www.asrm.org/practice-guidance/practice-committee-documents/diagnosis-and-treatment-of-infertility-in-men-aua-asrm-guideline-part2/

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.